Literature DB >> 23620117

Microbial biofilms and gastrointestinal diseases.

Erik C von Rosenvinge1, Graeme A O'May, Sandra Macfarlane, George T Macfarlane, Mark E Shirtliff.   

Abstract

The majority of bacteria live not planktonically, but as residents of sessile biofilm communities. Such populations have been defined as 'matrix-enclosed microbial accretions, which adhere to both biological and nonbiological surfaces'. Bacterial formation of biofilm is implicated in many chronic disease states. Growth in this mode promotes survival by increasing community recalcitrance to clearance by host immune effectors and therapeutic antimicrobials. The human gastrointestinal (GI) tract encompasses a plethora of nutritional and physicochemical environments, many of which are ideal for biofilm formation and survival. However, little is known of the nature, function, and clinical relevance of these communities. This review summarizes current knowledge of the composition and association with health and disease of biofilm communities in the GI tract.
© 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23620117      PMCID: PMC4395855          DOI: 10.1111/2049-632X.12020

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  127 in total

Review 1.  Immunotherapeutic strategies to combat staphylococcal infections.

Authors:  Knut Ohlsen; Udo Lorenz
Journal:  Int J Med Microbiol       Date:  2010-05-23       Impact factor: 3.473

Review 2.  Review article: prebiotics in the gastrointestinal tract.

Authors:  S Macfarlane; G T Macfarlane; J H Cummings
Journal:  Aliment Pharmacol Ther       Date:  2006-09-01       Impact factor: 8.171

3.  Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients.

Authors:  Graeme A O'May; Nigel Reynolds; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

4.  Bacteriological studies of experimental ulcerative colitis.

Authors:  A B Onderdonk; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

5.  Control of acid resistance in Escherichia coli.

Authors:  M P Castanie-Cornet; T A Penfound; D Smith; J F Elliott; J W Foster
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

6.  Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.

Authors:  E Furrie; S Macfarlane; A Kennedy; J H Cummings; S V Walsh; D A O'neil; G T Macfarlane
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

Review 7.  Prebiotics, synbiotics and inflammatory bowel disease.

Authors:  Helen Steed; George T Macfarlane; Sandra Macfarlane
Journal:  Mol Nutr Food Res       Date:  2008-08       Impact factor: 5.914

8.  Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells.

Authors:  Tonyia Eaves-Pyles; Christopher A Allen; Joanna Taormina; Alexander Swidsinski; Christopher B Tutt; G Eric Jezek; Martha Islas-Islas; Alfredo G Torres
Journal:  Int J Med Microbiol       Date:  2007-09-27       Impact factor: 3.473

9.  Outer membrane vesicles of Helicobacter pylori TK1402 are involved in biofilm formation.

Authors:  Hideo Yonezawa; Takako Osaki; Satoshi Kurata; Minoru Fukuda; Hayato Kawakami; Kuniyasu Ochiai; Tomoko Hanawa; Shigeru Kamiya
Journal:  BMC Microbiol       Date:  2009-09-15       Impact factor: 3.605

10.  The structure of CodY, a GTP- and isoleucine-responsive regulator of stationary phase and virulence in gram-positive bacteria.

Authors:  Vladimir M Levdikov; Elena Blagova; Pascale Joseph; Abraham L Sonenshein; Anthony J Wilkinson
Journal:  J Biol Chem       Date:  2006-02-17       Impact factor: 5.157

View more
  25 in total

1.  Extracellular matrix structure governs invasion resistance in bacterial biofilms.

Authors:  Carey D Nadell; Knut Drescher; Ned S Wingreen; Bonnie L Bassler
Journal:  ISME J       Date:  2015-01-20       Impact factor: 10.302

Review 2.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

3.  Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity.

Authors:  Paul M Gallo; Glenn J Rapsinski; R Paul Wilson; Gertrude O Oppong; Uma Sriram; Mark Goulian; Bettina Buttaro; Roberto Caricchio; Stefania Gallucci; Çagla Tükel
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

Review 4.  Metabolite and Microbiome Interplay in Cancer Immunotherapy.

Authors:  Caroline H Johnson; Mary E Spilker; Laura Goetz; Scott N Peterson; Gary Siuzdak
Journal:  Cancer Res       Date:  2016-10-11       Impact factor: 12.701

Review 5.  Biofilms: Formation, Research Models, Potential Targets, and Methods for Prevention and Treatment.

Authors:  Yajuan Su; Jaime T Yrastorza; Mitchell Matis; Jenna Cusick; Siwei Zhao; Guangshun Wang; Jingwei Xie
Journal:  Adv Sci (Weinh)       Date:  2022-08-28       Impact factor: 17.521

Review 6.  Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Kuldeep Dhama; Sang-Soo Lee
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 7.  Insights in the Development and Uses of Alternatives to Antibiotic Growth Promoters in Poultry and Swine Production.

Authors:  Md Ramim Tanver Rahman; Ismail Fliss; Eric Biron
Journal:  Antibiotics (Basel)       Date:  2022-06-02

8.  Pseudomonas aeruginosa Biofilm Formation and Persistence, along with the Production of Quorum Sensing-Dependent Virulence Factors, Are Disrupted by a Triterpenoid Coumarate Ester Isolated from Dalbergia trichocarpa, a Tropical Legume.

Authors:  Tsiry Rasamiravaka; Olivier M Vandeputte; Laurent Pottier; Joelle Huet; Christian Rabemanantsoa; Martin Kiendrebeogo; Abel Andriantsimahavandy; Andry Rasamindrakotroka; Caroline Stévigny; Pierre Duez; Mondher El Jaziri
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

9.  Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.

Authors:  Michael A Henson; Poonam Phalak
Journal:  BMC Syst Biol       Date:  2017-12-28

10.  Gastric bacterial Flora in patients Harbouring Helicobacter pylori with or without chronic dyspepsia: analysis with matrix-assisted laser desorption ionization time-of-flight mass spectroscopy.

Authors:  Verima Pereira; Philip Abraham; Sivaramaiah Nallapeta; Anjali Shetty
Journal:  BMC Gastroenterol       Date:  2018-01-26       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.